TITLE 844 MEDICAL LICENSING BOARD OF INDIANA
Notice of Intent to Adopt a Rule
LSA Document #14-289
Under
IC 4-22-2-23, the Medical Licensing Board of Indiana intends to adopt a rule concerning the following:
OVERVIEW: Adds
844 IAC 5-6 to establish requirements for the prescribing of opioid controlled substances for pain management. Public comments are invited and may be directed to the Medical Licensing Board of Indiana, Attention: Michael A. Minglin, J.D., Director, 402 West Washington Street, Room W072, Indianapolis, IN 46204 or by e-mail to mminglin@pla.in.gov. Statutory authority:
IC 25-22.5-2-7;
IC 25-22.5-13-2.
For purposes of
IC 4-22-2-28.1, the Small Business Regulatory Coordinator for this rule is:
Michael A. Minglin, J.D.
Indiana Professional Licensing Agency
Indiana Government Center South
402 West Washington Street, Room W072
Indianapolis, IN 46204
(317) 234-2060
mminglin@pla.in.gov
Erik Scheub
Office of Small Business and Entrepreneurship
One North Capitol, Suite 600
Indianapolis, IN 46204
(317) 232-5679
ombudsman@osbe.in.gov
Resources available to regulated entities through the small business ombudsman include the ombudsman's duties stated in
IC 4-4-35-8, specifically
IC 4-4-35-8(9), investigating and attempting to resolve any matter regarding compliance by a small business with a law, rule, or policy administered by a state agency, either as a party to a proceeding or as a mediator.
Posted: 07/16/2014 by Legislative Services Agency
DIN: 20140716-IR-844140289NIA
Composed: Mar 28,2024 9:50:27PM EDT
A
PDF version of this document.